HC Wainwright & Co. is very positive about SENS and gave it a « » rating on Aug 19, 2021 . The price target was set to 3.17+1.6.
…
Predicted Opening Price for Senseonics Holdings Inc of Tuesday, April 12, 2022.
| Fair opening price April 12, 2022 | Current price |
|---|---|
| $1.76 | $1.75 (Undervalued) |
Similarly, Why is SENS stock dropping?
What happened. Shares of Senseonics Holdings ( SENS -0.55% ) were sinking 14.3% as of 3:12 p.m. EDT on Thursday. The big drop came after the medical technology company announced the pricing of a public offering of its stock.
Is Senseonics a buy? Senseonics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Thereof, Did SENS get FDA approval?
(NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the approval of the next-generation Eversense® E3 CGM System by the Food and Drug Administration (FDA).
Is SENS a hold?
Senseonics Holdings, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. SENS has around 29.7M shares in the U.S. ETF market.
Who invested in SENS?
Top 10 Owners of Senseonics Holdings Inc
| Stockholder | Stake | Total value ($) |
|---|---|---|
| BlackRock Fund Advisors | 6.29% | 50,518,913 |
| The Vanguard Group, Inc. | 4.27% | 34,245,400 |
| SSgA Funds Management, Inc. | 2.56% | 20,565,578 |
| Masters Capital Management LLC | 1.57% | 12,600,000 |
What does SENS company do?
Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community.
Did BlackRock buy Sens stock?
ownership in SENS / Senseonics Holdings Inc. 2022-02-04 – BlackRock Inc. has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 31,075,724 shares of Senseonics Holdings Inc (US:SENS). This represents 7.0 percent ownership of the company.
Who owns the most Sens stock?
Largest shareholders include BlackRock Inc., Vanguard Group Inc, State Street Corp, VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, IWM – iShares Russell 2000 ETF, Masters Capital Management Llc, Geode Capital Management, Llc, VEXMX – Vanguard Extended Market Index Fund Investor Shares, Susquehanna …
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
What sector is SENS in?
Key Data
| Label | Value |
|---|---|
| Exchange | AMEX |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| 1 Year Target | $3.00 |
How many shares does SENS have?
Share Statistics
| Avg Vol (3 month) 3 | 13.61M |
|---|---|
| Shares Outstanding 5 | 463.15M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 333.03M |
| % Held by Insiders 1 | 9.91% |
When did Senseonics go public?
In connection with the offering, the common stock of Senseonics Holdings, Inc. has been approved for listing on the NYSE MKT. Trading is scheduled to commence on the NYSE MKT on Friday, March 18, 2016 under the symbol « SENS. »
Who owns Sensonic?
Strong partners, firmly established company values, an exciting corporate history and distinct characteristics: Get to know Sensonic – the youngest company of the Frauscher Group!
How many shares of Senseonics are there?
Share Statistics
| Avg Vol (3 month) 3 | 12.34M |
|---|---|
| Shares Outstanding 5 | 463.15M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 332.92M |
| % Held by Insiders 1 | 9.92% |
What is Fintel io?
Fintel.io is a leading equity research platform designed to help quant-driven investors make better investing decisions. Fintel provides deep analytics on a variety of market data, including fund ownership, insider trading activity, short interest, and company financials.
Who is the biggest investor in NIO?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Total value ($) |
|---|---|---|
| BlackRock Fund Advisors | 2.99% | 915,727,477 |
| The Vanguard Group, Inc. | 2.76% | 844,953,786 |
| SSgA Funds Management, Inc. | 2.45% | 751,155,776 |
| Goldman Sachs & Co. LLC (Private … | 1.73% | 529,951,450 |
What hedge funds are buying NIO?
NIO (NYSE:NIO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 3/9/2022 | Norges Bank | 0.864% |
| 2/25/2022 | Garde Capital Inc. | 0.000% |
| 2/23/2022 | Resources Investment Advisors LLC. | 0.001% |
| 2/23/2022 | BlackRock Inc. | 4.081% |
What mutual fund is NIO in?
ETF.com Insight
The largest ETF holder of NIO is the Vanguard FTSE Emerging Markets ETF (VWO), with approximately 13.04M shares. Investors may also find of interest that the ETF with the largest allocation to NIO stock is KraneShares MSCI China Clean Technology Index ETF (KGRN), with a portfolio weight of 8.18%.
What are the most shorted stocks?
Most Shorted Stocks Right Now
- Nikola Corporation (NASDAQ:NKLA) Number of Hedge Fund Holders: 12. Float Shorted: 30.02% …
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) Number of Hedge Fund Holders: 17. …
- SmileDirectClub, Inc. (NASDAQ:SDC) Number of Hedge Fund Holders: 18. …
- Beyond Meat, Inc. (NASDAQ:BYND) …
- Lemonade, Inc. (NYSE:LMND)
Is Sens a shorted stock?
Short Shares Availability
This table shows the number of shares of US:SENS available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
Who owns Eversense?
Ascensia Diabetes Care, a global diabetes care company, announces that it has launched the Eversense® NOW Remote Monitoring App for the Android Operating System in Europe.
Who manufactures Eversense?
Ascensia plans to make the Eversense E3 sensor, which can be used for up to 6 months, available to patients in the U.S. during the second quarter of 2022.
Does ascensia own Senseonics?
Ascensia will assume exclusive commercialization rights of Senseonics’ products for five years following U.S. availability of the 180-day Eversense product including the associated expenses, subject to extension in certain circumstances.
Join TheMoney.co community and don’t forget to share this post !
